Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by 42.86 percent. This is unchanged from the same period last year. The company reported quarterly sales of $50.593 million which beat the analyst consensus estimate of $50.000 million by 1.19 percent. This is a 27.90 percent increase over sales of $39.556 million the same period last year.
Viemed Healthcare Q1 2024 GAAP EPS $0.04 Misses $0.07 Estimate, Sales $50.593M Beat $50.000M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.